|
RS50101B
(sr)
|
1996-02-24 |
2009-01-22 |
Boehringer Ingelheim International Gmbh., |
Farmaceutski preparati za imunomodulaciju
|
|
DE19803453A1
(de)
*
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
DE69936355T2
(de)
*
|
1998-02-25 |
2008-02-21 |
The Government Of The United States, As Represented By The Secretary Of The Army |
Verwendung von Hautpenetrationsförderern und für die Zerstörung der oberen Hautschichten geeigneten Mitteln zur Erhöhung der transkutanen Immunantwort
|
|
CA2325818C
(en)
*
|
1998-04-20 |
2008-09-02 |
Torrey Pines Institute For Molecular Studies |
Topical immunostimulation to induce langerhans cell migration
|
|
AU783344B2
(en)
*
|
1999-02-17 |
2005-10-20 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
|
DE19909503A1
(de)
*
|
1999-03-04 |
2000-09-07 |
Boehringer Ingelheim Int |
Tumorassoziiertes Antigen
|
|
US6809179B1
(en)
|
1999-08-04 |
2004-10-26 |
Boehringer Ingelheim International Gmbh |
Tumor-associated antigen (R11)
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT409762B
(de)
*
|
2000-04-13 |
2002-11-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung von zytokin sekretierenden zellen
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
KR20020014459A
(ko)
*
|
2000-08-18 |
2002-02-25 |
서진호 |
양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
|
|
EP1347775B1
(en)
*
|
2001-01-05 |
2016-11-30 |
Valneva Austria GmbH |
Uses for polycationic compounds as vaccine adjuvants
|
|
EP1347776A2
(en)
*
|
2001-01-05 |
2003-10-01 |
Intercell Biomedizinische Forschungs- und Entwicklungs AG |
Anti-inflammatory use of polycationic compounds
|
|
US7244438B2
(en)
|
2001-01-05 |
2007-07-17 |
Intercell Ag |
Uses for polycationic compounds
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
CA2452909A1
(en)
*
|
2001-12-07 |
2003-06-13 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
US20050221350A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
CA2484941A1
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
AU2003258672B2
(en)
|
2002-09-13 |
2008-10-30 |
Intercell Ag |
Method for isolating hepatitis C virus peptides
|
|
EP2314603A3
(en)
|
2002-10-15 |
2011-05-18 |
Intercell AG |
Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and futher uses thereof
|
|
EP2287313A1
(en)
|
2003-03-04 |
2011-02-23 |
Intercell AG |
Streptococcus pyogenes antigens
|
|
EP2345420B1
(en)
|
2003-03-24 |
2016-01-06 |
Valneva Austria GmbH |
Use of a TH1 immune response inducing adjuvant for enhancing immune responses
|
|
WO2004087746A2
(en)
|
2003-03-31 |
2004-10-14 |
Intercell Ag |
Staphylococcus epidermidis antigens
|
|
EP2311991A1
(en)
|
2003-04-15 |
2011-04-20 |
Intercell AG |
S. pneumoniae antigens
|
|
CN101864432A
(zh)
|
2003-05-07 |
2010-10-20 |
英特塞尔股份公司 |
无乳链球菌抗原ⅰ和ⅱ
|
|
EP1629005A2
(en)
|
2003-05-30 |
2006-03-01 |
Intercell AG |
Enterococcus antigens
|
|
PL1648502T3
(pl)
|
2003-07-11 |
2011-05-31 |
Intercell Ag |
Szczepionki przeciwko HCV
|
|
EP1987843A3
(en)
|
2004-03-12 |
2011-10-26 |
Intercell AG |
Method for solubilising peptide mixtures
|
|
DE102004038134B4
(de)
|
2004-08-05 |
2013-07-25 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
EP1791858B1
(en)
|
2004-09-24 |
2010-04-21 |
Intercell AG |
Modified vp1-capsid protein of parvovirus b19
|
|
ES2327432T3
(es)
*
|
2004-10-29 |
2009-10-29 |
Intercell Ag |
Vacunas contra el vhc para pacientes con vhc cronica.
|
|
EP1872793B1
(en)
|
2005-04-20 |
2012-10-10 |
Mitsuru Akashi |
Polyamino acid for use as adjuvant
|
|
EP1887084A1
(en)
*
|
2006-08-10 |
2008-02-13 |
International Investment and Patents SA |
Plasmids with immunological action
|
|
EP2059526A2
(en)
|
2006-09-15 |
2009-05-20 |
Intercell AG |
Borrelia antigens
|
|
JP2008174490A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
抗原性ペプチドを主成分とする薬剤
|
|
EP2152731A2
(en)
|
2007-05-02 |
2010-02-17 |
Intercell AG |
Klebsiella antigens
|
|
KR100748265B1
(ko)
*
|
2007-06-15 |
2007-08-10 |
(주)성문엔지니어링 |
공동주택에 배선된 전선의 합선방지구조
|
|
CN101883782A
(zh)
|
2007-06-18 |
2010-11-10 |
英特塞尔股份公司 |
衣原体抗原
|
|
JP5654345B2
(ja)
|
2007-08-02 |
2015-01-14 |
ビオンドヴァックス ファーマシューティカルズ リミテッド |
多量体マルチエピトープインフルエンザワクチン
|
|
ES2703571T3
(es)
*
|
2008-03-27 |
2019-03-11 |
Nestec Sa |
Métodos para aumentar la absorción de péptidos, peptidomiméticos y otros sustratos de proteína de transporte gastrointestinal
|
|
US20110236470A1
(en)
|
2008-12-03 |
2011-09-29 |
Yaffa Mizrachi Nebenzahl |
GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
|
|
WO2010092176A2
(en)
|
2009-02-13 |
2010-08-19 |
Intercell Ag |
Nontypable haemophilus influenzae antigens
|
|
CN102740882A
(zh)
*
|
2009-08-27 |
2012-10-17 |
诺华有限公司 |
含有铝、寡核苷酸和聚阳离子的佐剂
|
|
WO2011057131A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
|
CN107033368A
(zh)
|
2009-11-09 |
2017-08-11 |
聚光灯技术合伙有限责任公司 |
碎裂水凝胶
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
WO2011101465A1
(en)
|
2010-02-19 |
2011-08-25 |
Intercell Ag |
Ic31 nanoparticles
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
RU2478399C2
(ru)
*
|
2011-06-16 |
2013-04-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) |
Способ получения специфического иммуномодулятора
|
|
US20140271723A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Saint Louis University |
Adjuvant compositions and methods of using thereof
|
|
JP6423889B2
(ja)
|
2014-10-07 |
2018-11-14 |
サイトリミック株式会社 |
Ｈｓｐ７０由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
JP6559898B2
(ja)
*
|
2015-12-16 |
2019-08-14 |
ヒュヴェット・バイオ・インコーポレイテッド |
スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物
|
|
JP6710004B2
(ja)
*
|
2016-03-15 |
2020-06-17 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
免疫療法のためのモニタリングまたは診断ならびに治療剤の設計
|
|
MX2018014602A
(es)
*
|
2016-05-27 |
2019-06-10 |
Etubics Corp |
Composiciones de vacunas neoepitopos y metodos de uso de las mismas.
|
|
JP6998880B2
(ja)
|
2016-10-11 |
2022-02-10 |
サイトリミック株式会社 |
医薬
|
|
CN107469067B
(zh)
*
|
2017-09-05 |
2018-06-19 |
浙江大学 |
一种多肽及其改造体在制备免疫调节药物中的应用
|
|
CN112218883A
(zh)
|
2018-04-26 |
2021-01-12 |
艾吉纳斯公司 |
热休克蛋白结合肽组合物及其使用方法
|
|
CN110870913A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
|
|
CN110870912A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用
|
|
CN117860879A
(zh)
*
|
2024-01-10 |
2024-04-12 |
广州医科大学附属肿瘤医院 |
一种纳米疫苗递送系统及其制备方法和应用
|